Lifecore Biomedical, Inc. \De\ (LFCR) Depreciation & Amortization (CF) (2016 - 2025)
Lifecore Biomedical, Inc. \De\ has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $1.9 million for Q2 2025.
- For Q2 2025, Depreciation & Amortization (CF) fell 4.97% year-over-year to $1.9 million; the TTM value through May 2025 reached $8.0 million, up 0.92%, while the annual FY2025 figure was $8.0 million, 0.92% up from the prior year.
- Depreciation & Amortization (CF) for Q2 2025 was $1.9 million at Lifecore Biomedical, Inc. \De\, down from $2.1 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $5.9 million in Q4 2021 and troughed at $1.8 million in Q4 2023.
- A 5-year average of $3.2 million and a median of $2.8 million in 2022 define the central range for Depreciation & Amortization (CF).
- Biggest five-year swings in Depreciation & Amortization (CF): increased 25.51% in 2021 and later crashed 50.41% in 2022.
- Year by year, Depreciation & Amortization (CF) stood at $5.9 million in 2021, then crashed by 50.41% to $2.9 million in 2022, then tumbled by 39.93% to $1.8 million in 2023, then rose by 15.74% to $2.0 million in 2024, then decreased by 6.36% to $1.9 million in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for LFCR at $1.9 million in Q2 2025, $2.1 million in Q1 2025, and $2.0 million in Q4 2024.